BioGaia AB Company Description

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula.

The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product.

The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels.

BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.

BioGaia AB (publ)

Country	Sweden
Founded	1990
Industry	Pharmaceutical Preparations
Employees	225
CEO	Theresa Agnew

Contact Details

Address: Kungsbroplan 3 Stockholm, 112 27 Sweden
Phone	46 8 55 52 93 00
Website	biogaiagroup.com

Stock Details

Ticker Symbol	0GTN
Exchange	London Stock Exchange
Share Class	Class B Shares
Fiscal Year	January - December
Reporting Currency	SEK
ISIN Number	SE0017769995
SIC Code	2834

Key Executives

Name	Position
Theresa P. Agnew	Chief Executive Officer and President
Peter Rothschild M.Sc. Econ., MBA	Founder and Chairman
Alexander Kotsinas M.Sc. (Eng.).	Executive Vice President and Chief Financial Officer
Ludvig Milesson	Chief Operating Officer
Gianfranco Grompone	Chief Scentific Officer
Caroline Mofors	Executive Vice President and Chief Legal Officer
Linda Hagglund	Chief Marketing Officer
Angelika Kjelldorff	Chief Human Resources Officer
Sebastian Heimfors	Chief Commercial Officer
Jonathan Gromark	Sustainability Manager